Supplementary Table from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Authors:
- Tae Won KimTKTae Won Kim
- Howard A. BurrisHBHoward A. Burris
- Maria J. de Miguel LukenMLMaria J. de Miguel Luken
- Michael J. PishvaianMPMichael J. Pishvaian
- Yung-Jue BangYung-Jue Bang
- Michael GordonMGMichael Gordon
- Ahmad AwadaAAAhmad Awada
- D. Ross CamidgeDCD. Ross Camidge
- F. Stephen HodiFHF. Stephen Hodi
- Grant A. McArthurGrant A. McArthur
- Wilson H. MillerWMWilson H. Miller
- Andres CervantesAndres Cervantes
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)